1,005
Participants
Start Date
June 8, 2017
Primary Completion Date
September 20, 2019
Study Completion Date
September 20, 2019
EMC2 Strategy
The intervention includes 1) distribution of simplified one-page medication guide summaries, 2) an automated follow-up call to assess medication safety and problematic side effects and 3) summary reports of call to providers with any concerns flagged for clinic follow-up.
Near North Health Services Corporation, Chicago
Collaborators (1)
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
NIH
Boston Medical Center
OTHER
University of North Carolina, Chapel Hill
OTHER
University of Illinois at Chicago
OTHER
Northwestern University
OTHER